BIO-FD&C Co.,Ltd. (KOSDAQ:251120)

BIO-FD&C Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	19,534	19,179	16,066	15,592	15,855	11,972
Revenue Growth	12.64%	19.37%	3.04%	-1.66%	32.44%	38.57%
Gross Profit Gross Profit Growth	12,949	12,874	11,214	11,029	10,996	7,077
Operating Income Operating Income Growth	6,098	6,253	4,853	5,034	4,881	3,138
Net Income Net Income Growth	6,407	6,666	4,501	5,585	4,335	2,908
Earnings Per Share EPS Growth	750.04	781.00	528.00	655.00	492.00	393.00
EPS Growth	2.88%	47.92%	-19.39%	33.13%	25.19%	17.66%

Revenue by Segment

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Growth Factor Complex Growth Factor Complex Growth	7,765	6,569	5,717	3,661	3,242
Plant Cell Plant Cell Growth	1,976	3,503	4,870	3,383	906.94
Extract Extract Growth	1,969	1,500	1,165	1,089	905.37
Plant Cell Complex Plant Cell Complex Growth	1,601	1,823	1,371	1,468	1,285
Protein Protein Growth	1,482	1,141	1,067	1,256	746.97
Peptide Peptide Growth	941.03	754.92	780.06	765.8	1,032
Complex Complex Growth	86.83	54.71	98.67	206.95	232.26
Manufactured Products - Other Manufactured Products - Other Growth	71.89	92.98	110.3	50.08	125.83
Research Service Research Service Growth	45	93.96	647.32	27.41	56.94
Other Other Growth	128.42	58.61	29.67	65.29	107

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	55,438	52,758	45,887	40,882	40,344	5,485
Total Debt Total Debt Growth	187.52	351.94	1,356	1,222	3,416	3,832
Net Cash (Debt) Net Cash Growth	55,251	52,406	44,531	39,661	36,928	1,653
Net Cash Growth	15.53%	17.69%	12.28%	7.40%	2134.45%	-26.37%
Net Cash Per Share Net Cash Per Share Growth	6468.97	6140.26	5223.86	4651.21	4190.90	223.38

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	6,437	7,279	6,037	6,047	5,573	3,687
Capital Expenditures CapEx Growth	-698.32	-974.37	-1,259	-1,989	-152.44	-7,017
Free Cash Flow Free Cash Flow Growth	5,738	6,304	4,779	4,057	5,421	-3,330
Free Cash Flow Growth	-12.12%	31.93%	17.77%	-25.15%	-	-

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	66.29%	67.13%	69.80%	70.74%	69.35%	59.11%
Operating Margin	31.22%	32.60%	30.20%	32.29%	30.78%	26.21%
Pretax Margin	40.48%	41.45%	32.54%	45.87%	34.33%	27.51%
Profit Margin	32.80%	34.76%	28.01%	35.82%	27.34%	24.29%
FCF Margin	29.38%	32.87%	29.74%	26.02%	34.19%	-27.82%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 4, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	12.00	20.61	26.70	21.98	34.10	-
Forward PE	-	15.86	16.11	-	-	-
P/FCF Ratio	13.64	21.79	25.15	30.26	27.27	-
PS Ratio	4.01	7.16	7.48	7.88	9.32	-

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 3, 2026

Data Sources Report a data error